期刊文献+

综合干预对老年人血浆溶血磷脂酸和磷脂酸水平影响 被引量:2

THE EFFECTS OF SYNTHESIS INTERVENTION ON THE CONTENTS OF LPA AND PA IN PLASMA OF THE ELDERLY
下载PDF
导出
摘要 [目的]通过对徐州市离休人员的LPA和PA的筛检、高危人群的干预及血栓预防知识的讲座,探讨LPA和PA在血栓预防中的作用。[方法]在2004年和2005年分别进行血浆LPA和PA含量测定,并对LPA和PA阳性人员进行药物干预。[结果]在老年人群中LPA和PA的阳性率较高,干预后2005年PA阳性率及LPA+PA阳性率明显降于2004年(P﹤0.01),特别是PA的阳性率降低的更为明显。2005年LPA和PA的含量明显低于2004年,干预组干预后LPA和PA值明显低于干预前及对照组,降低了形成缺血性疾病的危险性。[结论]LPA和PA的测定可以作为血栓预警和了解抗血栓药物疗效的一个十分重要的手段,适量的阿斯匹林可以降低血浆LPA和PA含量,同时配合血栓病防治的健康教育,是降低缺血性疾病发生率的有效途径。  [Objective]To explore the effects of LPA(lysophosphatidic acid)and PA(phosphatidic acid)on preventing thrombosis by screening LPA and PA of retired citizens in Xuzhou,intervening to the high risk population and giving lectures on thrombosis prevention.[Methods]The contents of the plasma LPA and PA of retired citizens were determined in 2004 and 2005,respectively. Then the persons whose LPA and PA were positive were intervened to with medicaments.[Results]The positive rates of LPA and PA among retired citizens were relatively high,and the positive rates of PA and LPA+PA reduced significantly(P﹤0.01)after intervention,especially that of PA. The contents of LPA and PA in 2005 were lower than those in 2004. The contents of LPA and PA were lower in the intervention group than those in controls and the group before intervention,which reduced the risk of forming ischemic diseases.[Conclusion]Determining the contents of LPA and PA can predict thrombus formation and can be important means to investigate the effects of anti-thrombus medicaments. It is an effective way to lower the incidence rate of ischemic diseases by low-dosage of aspirin which can decrease the contents of PLA and PA in plasma and suitable health education on prevention and treatment of ischemic diseases.
出处 《现代预防医学》 CAS 北大核心 2007年第18期3429-3430,共2页 Modern Preventive Medicine
基金 江苏省卫生厅预防医学基金科研课题(YZ200403)
关键词 老年人 溶血磷脂酸 磷脂酸 The elderly LPA PA
  • 相关文献

参考文献4

二级参考文献7

共引文献20

同被引文献27

  • 1罗娜,朱妍,张真稳.2型糖尿病患者大血管病变与活化血小板的相关性研究[J].中国实用内科杂志,2006,26(4):507-509. 被引量:10
  • 2Chung SM, Bae ON, Lim KM, et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesiele generation in human erythrocytes[J]. Arterioscler Thromb Vasc Biol, 2007,27 (2) : 414-421. 被引量:1
  • 3Aoki J. Mechanisms of lysophosphatidic acid production[J]. Semin Cell Dev Biol,2004,15(5):477-489. 被引量:1
  • 4Jalink K, Hordijk PL, Moolenaar WH. Growth factor- like effects of lysophosphatidic acid, a novel lipid mediator[J]. Biochim giophys Acta,1994,1198(2/3) :185-196. 被引量:1
  • 5Moolenaar WH. l.ysophosphatidic acid, a muhifunctional phospholipids messenger [J]. J Biol Chem, 1995, 270 ( 22 ): 12949-12952. 被引量:1
  • 6Siess W, Zangl KJ, Essler M, et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotie lesions[J]. Proc Natl Acad Sci U S A, 1999,96(12) :6931-6936. 被引量:1
  • 7Mclntyre TM, Pontsler AV, Silva AR, et al. Identification of an intracellular receptor for lysophosphatidie acid (LPA) : LPA is a transcellular PPARgamma agonist[J]. Proc Natl Acad Sci U S A,2003,100(1) : 131-136. 被引量:1
  • 8Colwell JA, Nesto RW. The platelet in diabetes: focus on prevention of ischemic events[J]. Diabetes Care, 2003,26 ( 7 ) : 2181-2188. 被引量:1
  • 9Zhang C, Baker DL, Yasuda S, et al. Lysophosphatidic acid induces neointima formation through PPARgamma activation [J]. J Exp Med,2004,199(6) :763-774. 被引量:1
  • 10Rizza C, Leitinger N, Yue J, et al. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaetion[J]. Lab Invest, 1999,79(10):1227-1235. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部